Vaccination recommendations by STIKO

Germany
9 February 2016

The national immunization schedule is developed by STIKO, and an updated version is usually published once a year (usually in August) in the Epidemiological Bulletin of the Robert Koch Institute. STIKO has translated the vaccination recommendations endorsed during the 79th and 81st STIKO meetings and which are considered enacted upon their publication on 24 August 2015.
 

german-flag.png

This 2015 version replaces the previous STIKO vaccination recommendations published in August 2014 in Epidemiologisches Bulletin (Epid. Bull.) 34/2014 of the Robert Koch Institute (RKI). The scientific rationale for the modified STIKO recommendations will be available in Epid. Bull. 35/2015, 36/2015, and 37/2015 on the RKI website (www.stiko.de/en).

 

Documents to download

More information on STIKO recommendations here.

Related News & Events

  • Germany
    Background paper

    the German NITAG publishes the background paper to the decision to recommend the vaccination with the inactivated herpes zoster subunit vaccine

    12.03.2019

    The STIKO recommends vaccination with the adjuvanted herpes zoster subunit (HZ/su) inactivated vaccine for the prevention of herpes zoster (HZ) and postherpetic neuralgia (PHN) for all people age 60 years and over (standard vaccination).

    Read more
  • Germany

    Digital communication for NITAGs is no longer optional!

    25.10.2016

    In September 2016, STIKO, the German NITAG, launched its own app, the first of its kind in the NITAG community. Anyone can download the app, which is compatible with Android or IOS, and access all STIKO’s recommendations. “This innovative digital project aims to strengthen relationships between healthcare workers and STIKO,” explain Ole Wichmann and Judith Koch from Robert Koch Institute. 

    Read more
  • SAGE

    new Interim Recommendations on Vaccination against Ebola Virus Disease from SAGE

    13.05.2019

    Over the last four weeks, the Ebola outbreak in the Eastern Provinces of the Democratic Republic of Congo (DRC) has deteriorated with a large increase in the number of cases1. A major factor in this rise is an increase in critical security incidents that have dramatically affected the ability to identify, follow up and vaccinate contacts successfully. This context challenges the implementation of ring vaccination based on the identification of contacts and contacts of contacts, as recommended by SAGE in April 2017 and confirmed by SAGE during its April 2019 meeting. Further, a potential vaccine shortage may manifest in case the outbreak expands further and/or is prolonged.

    Read more